RainDance Technologies Inc. hired Laura Deming to be the company’s senior vice president of product development and Joseph Malandrakis as senior product development counsel.
The Lexington, Mass.-based company, which makes microdroplet-based technologies for the life science and research markets, said Deming will oversee the long-range product planning and strategy.
"RainDance is experiencing breakthrough growth and this is a very exciting time to join the Company. I look forward to working closely with this exceptionally talented team as we bring quality novel high-throughput platforms, and innovative digital PCR and single cell analysis solutions to customers around the world," Deming said in prepared remarks.
The company in January raised $37.5 million in a Series D round. Investors Sherrill Neff from Quaker BioVentures and Jeffrey Samberg from Acadia Woods LLC joined the RainDance board in connection with the financing.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Vasomedical taps Jun Ma for CEO
Vasomedical signs Jun Ma as CEO. The new chief will make $200,000 per year in salary and will eligible to receive a bonus for the fiscal year ended May 31, and for each fiscal year thereafter. Ma shall also be eligible for an award under any long-term incentive compensation plan and grants of options and awards of shares of the company’s stock, as determined at the Board of Directors’ discretion. Ma’s agreement with the coimpany further provides for reimbursement of certain expenses, and certain severance benefits in the event of termination prior to the expiration date of the Agreement.
- Topera Medical creation management advisory board
Topera Medical announced the formation and initial appointments to its Management Advisory Board. Comprised of established leaders in the medical device industry with broad, multi-disciplinary backgrounds, the Management Advisory Board will provide guidance and counsel to support the company’s growth strategy and ensure alignment and execution of business objectives.
- BioStorage appoints bizdev director for Europe
BioStorage Technologies announced the appointment of Piet Smet as Director of Business Development for its Europe operations. Smet joins BioStorage Technologies with more than 20 years of experience in sales and operational management within the clinical research area. Smet will be responsible for leading the Europe sales team and overseeing the development of new and existing customer relationships.
- LipoScience taps Robert Greczyn Jr. and Woodrow Myers for board
LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance (NMR) technology, announced that Robert Greczyn Jr. and Dr. Woodrow Myers Jr. have joined the company’s board.
- Boston University taps new director of business development for medical devices
Medeiros recently joined Boston University’s Office of Technology Development as the Director of Business Development focusing on medical devices, diagnostics, and life science tools. He will manage a portfolio of medical technologies developed at BU and promote their commercialization by licensing the technologies to outside parties and/or by establishing new companies. The school also named Elizabeth Carlson to the Technology Development Office at Boston University. Prior to joining BU, Ms. Carlson worked as an Associate Counsel in Massachusetts Institute of Technology’s Office of General Counsel, where she was responsible for advising on a wide range of intellectual property and research matters.
- President of Credo-TM joins Neuro-Biotech Corp. board
Neuro-Biotech Corp. (OTC:MRES) announced that the president of Credo-TM, Mr Rustern Yusupov, will assume the position of Vice-President Marketing. Mr Yusupov will be based out of Credo-TM`s head office in Kazan, Russia. Mr Yusupov will help lead the implementation of Neuro-Biotech licensees’ network, particularly in the creation of its own "Technological Showcase" to support the training of technicians as well as the developments of new products.
- Aptiv Solutions appoints Michael McKelvey as VP and COO
Aptiv Solutions announced the appointment of Michael J. McKelvey, PhD as Executive Vice President and Chief Operating Officer. In this role, he is responsible for overseeing the US, European, and Japanese clinical operations as well as the information technology operations of the company.
- Cook Medical promotes Dan Sirota to VP of interventional radiology
Dan Sirota, who has served as global business leader for Cook Medical’s Interventional Radiology division since its inception in 2009, was promoted to vice president of that business unit, the company said.
- Baxter appoints James Saccaro as treasurer and corporate officer
Baxter International Inc. (NYSE:BAX) announced that its board elected James Saccaro as treasurer and a corporate officer of the company. Saccaro assumes the treasurer role from Robert J. Hombach, who was named the company’s chief financial officer in 2010.
- OptiMedica appoints David Scott to VP of R&D
Global ophthalmic company OptiMedica Corp. named David Scott as its new vice president of research and development. A seasoned scientist and medical device executive with 18 years of engineering program management and product development experience, Scott will be responsible for driving OptiMedica’s new technology and product innovation.
- Vuzix appoints two to board
Vuzix Corporation (CVE:VZX) announced that Jose Cecin and Richard Conway have been appointed to the Company’s Board of Directors bringing the total number of Board members to eight (8). The confirmation of Mr. Cecin and Mr. Conway as Board members satisfies the obligation of the Company, under its loan agreement with LC Capital Master Fund Ltd. (LC) to add two Board seats to represent the interests of LC.
- Tengion adds two renal experts to R&D panel
Tengion Inc. (NSDQ:TNGN) announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D. and Giuseppe Remuzzi, M.D., F.R.C.P., from the Harvard Stem Cell Instituteand Mario Negri Institute respectively, to its panel of Research & Development Advisors.
- Solta Medical COO joins MyoScience
Solta Medical Inc. (NSDQ:SLTM) CEO Clint Carnell advised Solta Medical, Inc. that he is resigning as the company’s COO to become CEO at MyoScience, Inc., a privately-held clinical stage company developing products for aesthetic medicine.
- Neuroscientist Christof Koch joins the Allen Institute as chief scientific officer
The Allen Institute for Brain Science, a nonprofit medical research organization dedicated to advancing understanding of the human brain, has appointed neuroscientist Christof Koch as chief scientific officer. Koch joins the Allen Institute after a 25-year tenure at the California Institute of Technology (Caltech).
- Echo Therapeutics adds two executives
Echo Therapeutics Inc. (OTC:ECTE) announced that John Garibotto and Kenneth Gary, who collectively have nearly fifty years of medical device and diagnostics experience, have joined Echo Therapeutics’ senior management team as part of the company’s plan to accelerate the development of the Symphony System and other new products contemplated in the Company’s growth strategy.
- Cantel Medical names Ann Berman to board
Cantel Medical Corp. (NYSE:CMN) announced the appointment of Ann E. Berman to serve as an independent member of Cantel’s Board of Directors. Ms. Berman is the former CFO (2002-2006) of Harvard University.